Capricor Therapeutics Stock Options
| CAPR Stock | USD 13.70 0.20 1.48% |
Capricor Therapeutics' latest option contracts expiring on March 21st 2025 are carrying combined implied volatility of 1.42 with a put-to-call open interest ratio of 0.2 over 26 outstanding agreements suggesting investors are buying way more calls than puts on contracts expiring on March 21st 2025. The total put volume is at 470, with calls trading at the volume of 151. This yields a 3.11 put-to-call volume ratio.
Open Interest Against March 21st 2025 Option Contracts
2025-03-21
The chart above shows Capricor Therapeutics' distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Capricor Therapeutics' open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Capricor Therapeutics' option, there is no secondary market available for investors to trade.
Capricor Therapeutics Maximum Pain Price Across 2025-03-21 Option Contracts
Max pain occurs when Capricor Therapeutics' market makers reach a net positive position across all Capricor Therapeutics' options at a strike price where option holders stand to lose the most money. By contrast, Capricor Therapeutics' option sellers may reap the most after selling more options than buying, causing them to expire worthless.
In The Money vs. Out of Money Option Contracts on Capricor Therapeutics
Analyzing Capricor Therapeutics' in-the-money options over time can help investors to take a profitable long position in Capricor Therapeutics regardless of its overall volatility. This is especially true when Capricor Therapeutics' options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Capricor Therapeutics' options could be used as guardians of the underlying stock as they move almost dollar for dollar with Capricor Therapeutics' stock while costing only a fraction of its price.
Capricor Therapeutics In The Money Call Balance
When Capricor Therapeutics' strike price is surpassing the current stock price, the option contract against Capricor Therapeutics stock is said to be in the money. When it comes to buying Capricor Therapeutics' options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Capricor Therapeutics are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.
Capricor Current Options Market Mood
Capricor Therapeutics' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Capricor Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Open Interest
Put-to-Call Volume
Unfortunately, most Capricor Therapeutics' options investors are not very successful. Capricor Therapeutics' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.
Rule 16 of the current Capricor contract
Base on the Rule 16, the options market is currently suggesting that Capricor Therapeutics will have an average daily up or down price movement of about 0.0888% per day over the life of the 2025-03-21 option contract. With Capricor Therapeutics trading at USD 13.7, that is roughly USD 0.0122. If you think that the market is fully incorporating Capricor Therapeutics' daily price movement you should consider buying Capricor Therapeutics options at the current volatility level of 1.42%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Capricor |
Purchasing Capricor Therapeutics options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Capricor calls. Remember, the seller must deliver Capricor Therapeutics stock to the call owner when a call is exercised.
Capricor Therapeutics Option Chain
When Capricor Therapeutics' strike price is surpassing the current stock price, the option contract against Capricor Therapeutics stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Capricor Therapeutics' option chain is a display of a range of information that helps investors for ways to trade options on Capricor. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Capricor. It also shows strike prices and maturity days for a Capricor Therapeutics against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Open Int | Strike Price | Current Spread | Last Price | |||
Call | CAPR250321C00002500 | 161 | 2.5 | 11.1 - 11.7 | 12.4 | In |
Call | CAPR250321C00005000 | 807 | 5.0 | 8.6 - 9.0 | 7.7 | In |
Call | CAPR250321C00007500 | 2494 | 7.5 | 6.4 - 7.2 | 6.6 | In |
Call | CAPR250321C00010000 | 583 | 10.0 | 4.6 - 4.9 | 3.9 | In |
Call | CAPR250321C00012500 | 242 | 12.5 | 3.1 - 3.7 | 3.15 | In |
Call | CAPR250321C00015000 | 600 | 15.0 | 1.85 - 2.9 | 2.2 | Out |
Call | CAPR250321C00017500 | 6554 | 17.5 | 1.2 - 1.8 | 1.45 | Out |
Call | CAPR250321C00020000 | 1268 | 20.0 | 0.65 - 1.65 | 1.0 | Out |
Call | CAPR250321C00022500 | 379 | 22.5 | 0.6 - 0.95 | 0.75 | Out |
Call | CAPR250321C00025000 | 1173 | 25.0 | 0.5 - 0.9 | 0.51 | Out |
Call | CAPR250321C00030000 | 763 | 30.0 | 0.0 - 0.65 | 0.25 | Out |
Call | CAPR250321C00035000 | 96 | 35.0 | 0.0 - 0.6 | 0.7 | Out |
Call | CAPR250321C00040000 | 504 | 40.0 | 0.0 - 0.55 | 0.15 | Out |
Put | CAPR250321P00002500 | 32 | 2.5 | 0.0 - 0.05 | 0.05 | Out |
Put | CAPR250321P00005000 | 418 | 5.0 | 0.1 - 0.6 | 0.27 | Out |
Put | CAPR250321P00007500 | 708 | 7.5 | 0.4 - 0.5 | 0.5 | Out |
Put | CAPR250321P00010000 | 888 | 10.0 | 0.75 - 1.45 | 1.13 | Out |
Put | CAPR250321P00012500 | 485 | 12.5 | 1.7 - 2.2 | 2.08 | Out |
Put | CAPR250321P00015000 | 237 | 15.0 | 3.0 - 3.6 | 3.54 | In |
Put | CAPR250321P00017500 | 102 | 17.5 | 4.9 - 6.2 | 6.36 | In |
Put | CAPR250321P00020000 | 121 | 20.0 | 6.8 - 7.6 | 7.82 | In |
Put | CAPR250321P00022500 | 22 | 22.5 | 9.2 - 10.1 | 10.65 | In |
Put | CAPR250321P00025000 | 16 | 25.0 | 11.3 - 12.4 | 11.48 | In |
Put | CAPR250321P00030000 | 70 | 30.0 | 16.2 - 16.7 | 13.58 | In |
Put | CAPR250321P00035000 | 1 | 35.0 | 19.9 - 23.3 | 22.31 | In |
Put | CAPR250321P00040000 | 0 | 40.0 | 24.0 - 28.9 | 24.0 | In |
Capricor Therapeutics Market Cap Over Time
Market Cap |
| Timeline |
Capricor Total Stockholder Equity
Total Stockholder Equity |
|
Capricor Therapeutics Corporate Management
| Deborah Ascheim | Chief Medical Officer | Profile | |
| Kristi Elliott | Chief Officer | Profile | |
| Xavier Avat | Chief Officer | Profile | |
| MD FACC | Executive Board | Profile | |
| Catherine Kelleher | Consultant | Profile | |
| Eduardo Marbn | CoFounder Board | Profile |
Additional Tools for Capricor Stock Analysis
When running Capricor Therapeutics' price analysis, check to measure Capricor Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Capricor Therapeutics is operating at the current time. Most of Capricor Therapeutics' value examination focuses on studying past and present price action to predict the probability of Capricor Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Capricor Therapeutics' price. Additionally, you may evaluate how the addition of Capricor Therapeutics to your portfolios can decrease your overall portfolio volatility.